| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 163.855 | 176.331 | 181.443 | 172.539 | 187.382 | 196.267 | 203.745 | 224.123 | 251.656 | 278.958 |
| Total Income - EUR | 170.796 | 180.553 | 184.786 | 175.577 | 187.621 | 196.802 | 203.841 | 224.897 | 253.662 | 280.804 |
| Total Expenses - EUR | 144.610 | 151.134 | 153.017 | 142.003 | 152.803 | 162.077 | 172.161 | 187.707 | 203.025 | 230.902 |
| Gross Profit/Loss - EUR | 26.186 | 29.419 | 31.769 | 33.574 | 34.818 | 34.725 | 31.680 | 37.191 | 50.637 | 49.901 |
| Net Profit/Loss - EUR | 21.903 | 24.649 | 29.491 | 31.819 | 32.845 | 32.851 | 29.641 | 35.279 | 48.354 | 41.646 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ages Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.162 | 3.672 | 140 | 137 | 1.259 | 1.612 | 1.424 | 1.594 | 1.870 | 2.199 |
| Current Assets | 96.877 | 63.059 | 76.724 | 103.819 | 117.630 | 134.405 | 152.143 | 176.936 | 189.447 | 117.723 |
| Inventories | 45.439 | 39.591 | 43.855 | 48.057 | 58.797 | 66.585 | 65.345 | 63.588 | 64.618 | 64.189 |
| Receivables | 25.407 | 15.074 | 22.558 | 25.485 | 21.152 | 29.943 | 30.864 | 31.408 | 25.823 | 20.745 |
| Cash | 26.031 | 8.393 | 10.311 | 30.278 | 37.681 | 37.877 | 55.933 | 81.940 | 99.006 | 32.789 |
| Shareholders Funds | 78.547 | 24.693 | 29.535 | 60.812 | 92.479 | 103.136 | 121.978 | 154.434 | 172.683 | 81.174 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 26.492 | 42.038 | 47.329 | 43.145 | 26.411 | 32.882 | 31.588 | 24.095 | 18.634 | 38.747 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Ages Pharm Srl